{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:02:46Z","timestamp":1772035366040,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    The recombination activating gene 1\n                    <jats:italic toggle=\"yes\">(RAG1)<\/jats:italic>\n                    is essential for V(D)J recombination and lymphocyte development. While biallelic null\n                    <jats:italic toggle=\"yes\">RAG1<\/jats:italic>\n                    mutations cause severe combined immunodeficiency (SCID), hypomorphic variants have increasingly been associated with immune dysregulation and hematologic malignancies. This study aimed to present a pediatric case of Epstein-Barr virus (EBV)-negative Burkitt lymphoma carrying a novel homozygous\n                    <jats:italic toggle=\"yes\">RAG1<\/jats:italic>\n                    variant and to discuss its potential association with immune function and malignancy risk. A 9-year-old Turkish male from a consanguineous family was evaluated for hereditary cancer predisposition. Clinical, immunologic, and genetic assessments were performed, including whole-exome sequencing (WES), Sanger validation, and mRNA expression analysis. The patient presented with cervical lymphadenopathy and was diagnosed with EBV-negative Burkitt lymphoma; he had no recurrent infections, abnormal vaccine reactions, or SCID-related features. Immunologic testing, including lymphocyte subsets and immunoglobulin levels, was within normal limits. WES identified a homozygous\n                    <jats:italic toggle=\"yes\">RAG1<\/jats:italic>\n                    variant (NM_000448.2:c.460C&gt;T; p.Leu154Phe), predicted to be deleterious and absent from population databases. Both the patient and his healthy dizygotic twin were homozygous, while parents were heterozygous carriers.\n                    <jats:italic toggle=\"yes\">RAG1<\/jats:italic>\n                    mRNA expression was reduced in heterozygotes but similar in homozygous and wild-type individuals; enzymatic activity was not assessed. The patient responded to chemotherapy and remains in remission under follow-up. In conclusion, this case expands the phenotypic spectrum of hypomorphic\n                    <jats:italic toggle=\"yes\">RAG1<\/jats:italic>\n                    variants to include EBV-negative Burkitt lymphoma without overt immunodeficiency, suggesting a possible link between partial\n                    <jats:italic toggle=\"yes\">RAG1<\/jats:italic>\n                    dysfunction and pediatric lymphoma susceptibility.\n                  <\/jats:p>","DOI":"10.1097\/mph.0000000000003159","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T19:00:41Z","timestamp":1768503641000},"page":"e97-e101","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Germline Homozygous RAG1 Missense Variant Associated With Epstein-Barr Virus Negative Childhood Burkitt Lymphoma"],"prefix":"10.1097","volume":"48","author":[{"given":"Nurana","family":"Mammadova","sequence":"first","affiliation":[{"name":"Department of Medical Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulbaki","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye","family":"Gokce","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"Ozcan","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Department, School of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa","family":"Karakukcu","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology Department, School of Medicine, Erciyes University, Kayseri, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-4611","authenticated-orcid":false,"given":"Munis","family":"Dundar","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"R1-20260225","doi-asserted-by":"crossref","first-page":"RP91030","DOI":"10.7554\/eLife.91030","article-title":"RAG1 and RAG2 non-core regions are implicated in leukemogenesis and off-target V(D)J recombination in BCR-ABL1-driven B-cell lineage lymphoblastic leukemia","volume":"12","author":"Yu","year":"2024","journal-title":"Elife"},{"key":"R2-20260225","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1415020","article-title":"Infant with diffuse large B-cell lymphoma identified postmortem with homozygous founder Slavic RAG1 variant: a case report and literature review","volume":"12","author":"Volodashchik","year":"2024","journal-title":"Front Pediatr"},{"key":"R3-20260225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/imm.12009","article-title":"Role of recombination activating genes in the generation of antigen receptor diversity and beyond","volume":"137","author":"Nishana","year":"2012","journal-title":"Immunology"},{"key":"R4-20260225","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.7150\/jca.33989","article-title":"RAG1 high expression associated with IKZF1 dysfunction in adult B-cell acute lymphoblastic leukemia","volume":"10","author":"Han","year":"2019","journal-title":"J Cancer"},{"key":"R5-20260225","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"key":"R6-20260225","doi-asserted-by":"crossref","first-page":"109393","DOI":"10.1016\/j.clim.2023.109393","article-title":"Diffuse large B-cell lymphoma in 1-year male with founder Slavic RAG1 mutation: case report","volume":"250","author":"Volodashchik","year":"2023","journal-title":"Clin Immunol"},{"key":"R7-20260225","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jaci.2014.04.042","article-title":"A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency","volume":"134","author":"Abolhassani","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R8-20260225","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/08880018.2020.1767739","article-title":"Clinical value of RAG1 expression and IKZF1 deletions in Philadelphia negative pediatric B cell precursor acute lymphoblastic leukemia","volume":"37","author":"Aref","year":"2020","journal-title":"Pediatr Hematol Oncol"},{"key":"R9-20260225","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1002\/cam4.3928","article-title":"RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children","volume":"10","author":"Chen","year":"2021","journal-title":"Cancer Med"},{"key":"R10-20260225","first-page":"735","article-title":"\u6210\u4ebaB\u7ec6\u80de\u6025\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\u4e2dRAG1\u8868\u8fbe\u7684\u7279\u5f81\u53ca\u4e34\u5e8a\u610f\u4e49","volume":"27","author":"Q","year":"2019","journal-title":"\u4e2d\u56fd\u5b9e\u9a8c\u8840\u6db2\u5b66\u6742\u5fd7"},{"key":"R11-20260225","first-page":"1","article-title":"A variant of RAG1 gene identified in severe combined immunodeficiency: a case report","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Pediatr"},{"key":"R12-20260225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.00900","article-title":"The clinical and genetic spectrum of 82 patients with RAG deficiency including a c.256_257delAA founder variant in slavic countries","volume":"11","author":"Sharapova","year":"2020","journal-title":"Front Immunol"},{"key":"R13-20260225","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10875-021-01052-0","article-title":"Clinical manifestations, mutational analysis, and immunological phenotype in patients with RAG1\/2 mutations: first cases series from Mexico and description of two novel mutations","volume":"41","author":"Lugo-Reyes","year":"2021","journal-title":"J Clin Immunol"},{"key":"R14-20260225","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41375-020-0751-y","article-title":"Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia","volume":"34","author":"Thomson","year":"2020","journal-title":"Leukemia"},{"key":"R15-20260225","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-07-165167","article-title":"Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation","volume":"113","author":"Giblin","year":"2009","journal-title":"Blood"},{"key":"R16-20260225","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2010-09-305383","article-title":"Loss of p19Arf in a Rag1-\/- B-cell precursor population initiates acute B-lymphoblastic leukemia","volume":"118","author":"Hauer","year":"2011","journal-title":"Blood"},{"key":"R17-20260225","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1182\/blood.V114.22.3971.3971","article-title":"Leukemia prone B-precursor population in a p19ARF-\/-RAG1-\/- mouse model","volume":"114","author":"Hauer","year":"2009","journal-title":"Blood"},{"key":"R18-20260225","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2017-12-820985","article-title":"Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development","volume":"132","author":"Ott de Bruin","year":"2018","journal-title":"Blood"},{"key":"R19-20260225","doi-asserted-by":"crossref","first-page":"e1248","DOI":"10.1542\/peds.2009-3171","article-title":"Highly variable clinical phenotypes of hypomorphic RAG1 mutations","volume":"126","author":"Avila","year":"2010","journal-title":"Pediatrics"},{"key":"R20-20260225","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.2022017667","article-title":"Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT","volume":"141","author":"Schuetz","year":"2023","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:00:38Z","timestamp":1772031638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003159"}},"subtitle":["A Case Report"],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003159","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"2025-06-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}